首页> 外国专利> Probiotic therapy delivered to women by oral administration of selected lactobascilli that have antagonistic properties against urogenital pathogens

Probiotic therapy delivered to women by oral administration of selected lactobascilli that have antagonistic properties against urogenital pathogens

机译:通过口服施用对泌尿生殖道病原体具有拮抗特性的选定乳杆菌对妇女进行益生菌治疗

摘要

Described are formulations for the prevention of infection and/or abnormal conditions of mucosae and/or skin caused by any pathogen and/or any disease, and more particularly for the prevention of sexually transmitted infections, HIV and HSV in particular, and herpetic lesions. The formulations could be used as a prophylactic agent to prevent accidental infection of health care workers. They could be used also for the healing and/or treatment of burn wounds and prevention of further infection. Also described is the development of a unique vaginal/ano-rectal applicator for the uniform delivery of any topical formulations to treat and/or prevent any infection and/or abnormal conditions of mucosa cavity caused by any pathogen and/or disease.
机译:描述了用于预防由任何病原体和/或任何疾病引起的感染和/或粘膜和/或皮肤的异常状况的制剂,更特别地用于预防性传播感染,尤其是HIV和HSV以及疱疹性病变的制剂。该制剂可用作预防剂,以防止医护人员意外感染。它们还可以用于烧伤伤口的愈合和/或治疗以及预防进一步的感染。还描述了独特的阴道/肛门直肠涂药器的开发,该涂药器用于均匀地递送任何局部制剂以治疗和/或预防由任何病原体和/或疾病引起的粘膜腔的任何感染和/或异常状况。

著录项

  • 公开/公告号NZ512275A

    专利类型

  • 公开/公告日2003-11-28

    原文格式PDF

  • 申请/专利权人 UREX BIOTECH INC;

    申请/专利号NZ19990512275

  • 发明设计人 REID GREGOR;BRUCE ANDREW W;

    申请日1999-12-10

  • 分类号A61K35/74;C12Q1/68;A61P31/04;A23C9/123;

  • 国家 NZ

  • 入库时间 2022-08-21 23:09:24

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号